Reps. Upton, Bishop Call For Compounding Report Language To Be Stripped From FDA Funding Bill

July 28, 2017 at 6:53 PM
Former House Energy & Commerce Committee Chair Fred Upton (R-MI) and Rep. Michael Bishop (R-MI) are calling for appropriators to strip report language from the FDA funding bill that encourages FDA to allow office-use compounding. While the report language asserts that FDA's current policy effectively banning office-use compounding goes against congressional intent, Upton and Bishop argue that compounders are using the report language to rewrite the legislative intent behind the Drug Quality and Security Act (DQSA). The compounding industry argues...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.